Enforced sialyl‐Lewis‐X (sLeX) display in E‐selectin ligands by exofucosylation is dispensable for CD19‐CAR T‐cell activity and bone marrow homing-Reference-Cited by-同舟云学术

Enforced sialyl‐Lewis‐X (sLeX) display in E‐selectin ligands by exofucosylation is dispensable for CD19‐CAR T‐cell activity and bone marrow homing

Published:2021-02 Issue:2 Volume:11 Page:
ISSN:2001-1326
Container-title:Clinical and Translational Medicine
language:en
Short-container-title:Clinical and Translational Medicine

Author:

Sánchez‐Martínez Diego¹^ORCID,Gutiérrez‐Agüera Francisco¹,Romecin Paola¹,Vinyoles Meritxell¹,Palomo Marta¹,Tirado Néstor¹,Zanetti Samanta Romina¹,Juan Manel²,Carlet Michela³⁴,Jeremias Irmela³⁴,Menéndez Pablo¹⁵⁶⁷

Affiliation:

1. Department of Biomedicine, Josep Carreras Leukemia Research Institute, School of Medicine University of Barcelona Barcelona Spain

2. Servei d'Immunologia Hospital Clínic de Barcelona Barcelona Spain

3. Department of Apoptosis in Hematopoietic Stem Cells, Helmholtz Center Munich German Center for Environmental Health (HMGU) Munich Germany

4. Department of Pediatrics Dr von Hauner Children's Hospital, LMU Munich Germany

5. Department of Biomedicine, School of Medicine University of Barcelona Barcelona Spain

6. Centro de Investigación Biomédica en Red‐Oncología (CIBERONC) Instituto de Salud Carlos III Madrid Spain

7. Institució Catalana de Recerca i Estudis Avançats (ICREA) Barcelona Spain

Funder

European Research Council

“la Caixa” Foundation

Publisher

Wiley

Subject

Molecular Medicine,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ctm2.280

Reference40 articles.

1. Adoptive cell therapy: honing that killer instinct;Humphries C;Nature,2013

2. Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia

3. Tumor Antigen Escape from CAR T-cell Therapy

4. Safety and persistence of adoptively transferred autologous CD19-targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias

5. B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor–transduced T cells

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Glycoengineering in antigen-specific immunotherapies;Current Opinion in Chemical Biology;2024-08

2. Microengineered In Vitro Assays for Screening and Sorting Manufactured Therapeutic T Cells;The Journal of Immunology;2024-01-15

3. Glycosyltransferases as versatile tools to study the biology of glycans;Glycobiology;2023-11-13

4. CAR T Cell Therapy: Remedies of Current Challenges in Design, Injection, Infiltration and Working;Drug Design, Development and Therapy;2023-06

5. Live‐Cell Glycocalyx Engineering;ChemBioChem;2023-02-21